Severity, risk factors, and physician practices in the management of anemia during concurrent chemoradiation for head and neck carcinoma

Cancer

Volumn 106, Issue 7, 2006, Pages 1554-1559

  Tanvetyanon, Tawee ^a,b   Choudhury, Abdul M ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b LOYOLA UNIVERSITY CHICAGO   (United States)

Author keywords

Anemia; Complication; Concurrent chemoradiation; Head and neck carcinoma; Transfusion

Indexed keywords

CARBOPLATIN; CISPLATIN; DOCETAXEL; ERYTHROPOIETIN; FLUOROURACIL; HEMOGLOBIN; NOVEL ERYTHROPOIESIS STIMULATING PROTEIN; PACLITAXEL;

ADULT; AGED; ANEMIA; BLOOD TRANSFUSION; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FOLLOW UP; HEAD AND NECK CARCINOMA; HEALTH SERVICE; HEMOGLOBIN DETERMINATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL PRACTICE; MEDICAL RECORD; PRIORITY JOURNAL; REVIEW; RISK FACTOR;

AGED; ANEMIA; CARCINOMA; COMBINED MODALITY THERAPY; FEMALE; HEAD AND NECK NEOPLASMS; HEMOGLOBINS; HUMANS; MALE; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; PROGNOSIS; QUALITY OF LIFE; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL ANALYSIS;

EID: 33645808476     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.21769     Document Type: Review

References (28)

1. Skillings JR, Sridhar FG, Wong C, Paddock L. The frequency of red cell transfusion for anemia in patients receiving chemotherapy. A retrospective cohort study. Am J Clin Oncol. 1993;16:22-25.
2. Argiris A, Li Y, Murphy BA, Langer CJ, Forastiere AA. Outcome of elderly patients with recurrent or metastatic head and neck cancer treated with cisplatin-based chemotherapy. J Clin Oncol. 2004;22:262-268.
3. Adelstein DJ, Li Y, Adams GL, et al. An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer. J Clin Oncol. 2003;21:92-98.
4. Ludwig H, Fritz E. Anemia in cancer patients. Semin Oncol. 1998;25(3 Suppl 7):2-6.
5. Crawford J, Cella D, Cleeland CS, et al. Relationship between changes in hemoglobin level and quality of life during chemotherapy in anemic cancer patients receiving epoetin alfa therapy. Cancer. 2002;95:888-895.
6. Grogan M, Thomas GM, Melamed I, et al. The importance of hemoglobin levels during radiotherapy for carcinoma of the cervix. Cancer. 1999;86:1528-1536.
7. Fein DA, Lee WR, Hanlon AL, et al. Pretreatment hemoglobin level influences local control and survival of T1-T2 squamous cell carcinomas of the glottic larynx. J Clin Oncol. 1995;13:2077-2083.
8. Grant DG, Hussain A, Hurman D. Pre-treatment anaemia alters outcome in early squamous cell carcinoma of the larynx treated by radical radiotherapy. J Laryngol Otol. 1999;113:829-833.
9. Lee WR, Berkey B, Marcial V, et al. Anemia is associated with decreased survival and increased locoregional failure in patients with locally advanced head and neck carcinoma: a secondary analysis of RTOG 85-27. Int J Radiat Oncol Biol Phys. 1998;42:1069-1075.
10. Greven KM, Solin LJ, Hanks GE. Prognostic factors in patients with bladder carcinoma treated with definitive irradiation. Cancer. 1990;65:908-912.
11. Evans JC, Bergsjo P. The influence of anemia on the results of radiotherapy in the carcinoma of cervix. Radiology. 1965;84:709-717.
12. Dunphy EP, Petersen IA, Cox RS, Bagshaw MA. The influence of initial hemoglobin and blood pressure levels on results of radiation therapy for carcinoma of the prostate. Int J Radiat Oncol Biol Phys. 1989;16:1173-1178.
13. Rockwell S. Oxygen delivery: implications for the biology and therapy of solid tumors. Oncol Res. 1997;9:383-390.
14. Stadler P, Feldmann HJ, Creighton C, Kau R, Molls M. Changes in tumor oxygenation during combined treatment with split-course radiotherapy and chemotherapy in patients with head and neck cancer. Radiother Oncol. 1998;48:157-164.
15. Acs G, Acs P, Beckwith SM, et al. Erythropoietin and erythropoietin receptor expression in human cancer. Cancer Res. 2001;61:3561-3565.
16. Yasuda Y, Fujita Y, Matsuo T, et al. Erythropoietin regulates tumour growth of human malignancies. Carcinogenesis. 2003;24:1021-1029.
17. Rizzo JD, Lichtin AE, Woolf SH, et al. Use of epoetin in patients with cancer: evidence-based clinical practice guidelines of the American Society of Clinical Oncology and the American Society of Hematology. J Clin Oncol. 2002;20:4083-4107.
18. Henke M, Laszig R, Rube C, et al. Erythropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy: randomised, double-blind, placebo-controlled trial. Lancet. 2003;362:1255-1260.
19. Greene FL, Page DL, Fleming ID, et al, editors. AJCC cancer staging manual, 6th ed. New York: Springer-Verlag, 2002.
20. Milano G, Caldani C, Khater R, et al. Time- and dose-dependent inhibition of erythrocyte glutathione peroxidase by cisplatin. Biochem Pharmacol. 1988;37:981-982.
21. [no authors listed]. Practice strategies for elective red blood cell transfusion. American College of Physicians. Ann Intern Med. 1992;116:403-406.
22. Murphy MF, Wallington TB, Kelsey P, et al. British Committee for Standards in Haematology, Blood Transfusion Task Force. Guidelines for the clinical use of red cell transfusions. Br J Haematol. 2001;113:24-31.
23. Machtay M, Pajak T, Suntharalingam M, et al. Definitive radiotherapy +/- erythropoietin for squamous cell carcinoma of the head and neck: preliminary report of RTOG 99-03. Int J Radiat Oncol Biol Phys. 2004;60:S132.
24. Leyland-Jones B. Breast cancer trial with erythropoietin terminated unexpectedly. Lancet Oncol. 2003;4:459-460.
25. Janda M, Newman B, Obermair A, et al. Impaired quality of life in patients commencing radiotherapy for cancer. Strahlenther Onkol. 2004;180:78-83.
26. Fang F, Liu Y, Tang Y, Wang C, Ko S. Quality of life as a survival predictor for patients with advanced head and neck carcinoma treated with radiotherapy. Cancer. 2004;100:425-432
27. Littlewood TJ, Bajetta E, Nortier JW, Vercammen E, Rapoport B. Effects of epoetin alfa on hematologic parameters and quality of life in cancer patients receiving nonplatinum chemotherapy: results of a randomized, double-blind, placebo-controlled trial. J Clin Oncol. 2001;19:2865-2874.
28. Goodnough LT. Risks of blood transfusion. Crit Care Med. 2003;31(12 Suppl):S678-S686.